lewy body dementia
-
alpha-synuclein co-pathology, alpha-synuclein SAA, ALZAN cohort, Alzheimer’s disease, Brain, CSF biomarkers, lewy body dementia, memory clinic biomarkers, Neurodegenerative Diseases, neuroscience, RT-QuICAlpha-Synuclein SAA Detected 95% of Lewy Body Dementia in ALZAN
A 2026 ALZAN memory-clinic cohort found that cerebrospinal-fluid alpha-synuclein seed amplification assay…
-
Brain, cholinergic, cognition, cognitive fluctuations, Diagnosis, DLB, donepezil, lewy body dementia, Mayo Fluctuations Composite, Neurodegenerative Diseases, neuroleptic sensitivity, neuroscience, Parkinson’s dementia, REM sleep behavior disorder, rivastigmine, sleepLewy Body Dementia Cognitive Fluctuations Affect 75-90% of Patients
Cognitive fluctuations are a defining feature of dementia with Lewy bodies (DLB),…
